A growing number of employers are expanding health coverage to in-vitro fertilization, surrogacy and other sometimes pricey fertility services in order to compete in the tight labor market amid heightened awareness of women's health.
Why it matters: An estimated 1.1 million women left the workforce during the pandemic, accounting for more than 63% of jobs lost, per Harvard Business Review. And the overturning of Roe v. Wade has scrambled the calculus for job-based reproductive health coverage.
